Products
Online Inquiry
Pomalidomide (CC-4047)
Cat. No.:
OB0225WX-2425
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, and HPLC.
Size:
Add to basket
Product Overview
Description:
Pomalidomide (CC-4047) is a ligand for the cereblon (CRBN) E3 ubiquitin ligase that inhibits LPS-induced TNF-alpha release (IC50: 13 nM) and is frequently utilized in the design of PROTAC molecules.
Synonym:
CC-4047; 19171-19-8; Pomalidomide; Actimid; 4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione; Pomalyst; Imnovid; 4-Aminothalidomide; 4-Amino-2-(2,6-dioxo-3-piperidyl)isoindoline-1,3-dione; 1H-Isoindole-1,3(2H)-dione, 4-amino-2-(2,6-dioxo-3-piperidinyl)-; IMiD 3; CC 4047; IMID-3; 3-Amino-N-(2,6-dioxo-3-piperidyl)phthalimide; CC4047; 4-Amino-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione; MFCD12756407; 3-Aminio-phthalimido-glutarimide; 4-Amino-2-(2,6-dioxopiperidin-3-yl)-2,3-dihydro-1H-isoindole-1,3-dione; 4-Amino-2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione; Phthalimide, 3-amino-N-(2,6-dioxo-3-piperidyl)-; 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline; Pomalidomidum; Pomalidomid; Pomalidomida; 4-Amino-2-[(3RS)-2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione
CAS No.:
19171-19-8
Compound CID:
134780
Formula:
C13H11N3O4
Formula Weight:
273.24
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Pomalidomide (CC-4047) is employed in immunology and oncology research as a potent immunomodulatory agent to study the degradation of transcription factors and the inhibition of TNF-alpha production in plasma cell dyscrasias.
Library Information
Target:
E3 Ligase ; E3 ligase ligand; TNF-alpha
Receptor:
E3 Ligase ; E3 ligase ligand; TNF-alpha
Pathways:
Ubiquitin
Plate Number:
L6700-02
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
54 mg/mL; 197.63 mM
ALogP:
-0.65
HBA_Count:
4
HBD_Count:
2
Rotatable Bond:
1



